You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Oligodendrogliomas

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

Recruiting
  • Astrocytoma, Grades II, III and IV
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Proteomic Characterization of Aggressive Oligodendrogliomas

Recruiting
  • Oligodendroglioma
  • Proteomic analysis
  • Bron, France
  • +1 more
Apr 12, 2021

Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)

Recruiting
  • Oligodendroglioma
  • +2 more
  • PCV chemotherapy
  • Radiotherapy and PCV chemotherapy
  • Amiens, France
  • +25 more
Jun 14, 2022

Clinical Development of Cancer-Specific MRS Biomarkers in

Completed
  • Malignant Gliomas
  • +2 more
  • 3 Tesla scanning
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 19, 2022

Clinical Development of MR Spectroscopy and Imaging in Brain

Completed
  • Malignant Gliomas
  • +2 more
  • 3 Tesla Scanning
  • 7 Tesla Scanning
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 19, 2022

Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Nov 3, 2021

Anaplastic Oligodendroglioma, Oligoastrocytoma, Oligodendroglioma Trial in Los Angeles (Wear novoTTF-200A, Quality-of-Life

Withdrawn
  • Anaplastic Oligodendroglioma
  • +2 more
  • Wear novoTTF-200A
  • Quality-of-Life Assessment
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Dec 8, 2020

Brain and CNS Tumors Trial in Canada, United States (drug, procedure, radiation)

Completed
  • Brain and Central Nervous System Tumors
  • Mobile, Alabama
  • +38 more
Oct 21, 2020

Oligodendroglioma; Oligoastrocytoma Trial in Marseille (Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide)

Completed
  • Oligodendroglioma; Oligoastrocytoma
  • Bis-Chloroethyl-Nitroso-Urea (BCNU) withTemozolomide
  • Marseille, France
    Assistance Publique - Hôpitaux de Marseille
Feb 11, 2021

Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

Active, not recruiting
  • Oligodendroglioma
  • +5 more
  • GBM6-AD and poly-ICLC before and after surgery
  • GBM6-AD and poly-ICLC after surgery only
  • San Francisco, California
    University of California
Sep 20, 2022

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Recruiting
  • Brain Tumor, Primary
  • Blood, CSF and tumor samples
  • Milan, Italy
    IRCCS San Raffaele Scientific Institute
Mar 16, 2023

CNS Cancer, CNS BRAIN Trial in Basking Ridge, Commack, New York (temozolomide followed by high dose busulfan and thiotepa)

Active, not recruiting
  • CNS Cancer
  • CNS BRAIN
  • temozolomide followed by high dose busulfan and thiotepa
  • Basking Ridge, New Jersey
  • +2 more
Oct 7, 2021

Oligodendroglioma Trial in Germany (CETEG, PCV, RT)

Recruiting
  • Oligodendroglioma
  • Heidelberg, Baden-Württemberg, Germany
  • +18 more
Sep 22, 2022

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed
  • Anaplastic Oligoastrocytoma
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
Mar 11, 2022

High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

Recruiting
  • High Grade Glioma
  • +12 more
  • LUTATHERA® (Lutetium Lu 177 dotatate)
  • Aurora, Colorado
  • +8 more
Jan 16, 2023

The circTeloDIAG: Liquid Biopsy for Glioma Tumor

Recruiting
  • Glioma
  • ctDNA analysis
  • Bron, France
    East Group Hospital, Hospices Civils de Lyon
Aug 2, 2021

Glioblastoma, Glioma Trial in Denmark, Netherlands, United States (Selinexor)

Terminated
Has Results
  • Glioblastoma
  • Glioma
  • Boston, Massachusetts
  • +5 more
Jan 24, 2023

Glioma Trial in Paris (MRI)

Not yet recruiting
  • Glioma
  • MRI
  • Paris, France
    Pitié-Salpetrière Hospital
Jan 27, 2023

Long Term Implications of Rare Brain Tumours'

Recruiting
  • Quality of Life
  • +5 more
  • Health-related Quality of Life
  • +3 more
  • Amsterdam, North Hollan, Netherlands
  • +1 more
Jan 11, 2021

Glioma of Brain Trial in Leuven

Recruiting
  • Glioma of Brain
    • Leuven, Vlaams-Brabant, Belgium
      UZ Leuven
    Nov 20, 2020

    Astrocytoma, Glioma, Oligodendroglioma Trial in Tampa (Irinotecan Hydrochloride (HCI) Treatment, Continued Irinotecan

    Terminated
    Has Results
    • Astrocytoma
    • +2 more
    • Irinotecan Hydrochloride (HCI) Treatment
    • Continued Irinotecan Hydrochloride (HCI) Treatment
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Feb 20, 2017

    Oligodendroglioma, Adult Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))

    Terminated
    Has Results
    • Oligodendroglioma, Adult
    • Antineoplaston therapy (Atengenal + Astugenal)
    • Houston, Texas
      Burzynski Clinic
    Mar 7, 2018

    Adult Anaplastic Oligodendroglioma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in United States (Imatinib Mesylate,

    Completed
    Has Results
    • Adult Anaplastic Oligodendroglioma
    • +3 more
    • Imatinib Mesylate
    • +2 more
    • Scottsdale, Arizona
    • +228 more
    Oct 4, 2019

    Brain and CNS Tumors Trial in United States (lomustine, procarbazine HCl, vincristine sulfate)

    Completed
    • Brain and Central Nervous System Tumors
    • Mobile, Alabama
    • +94 more
    Jun 15, 2018

    Human Autoantibody Titers After Central Nervous System Insult

    Unknown status
    • Brain Injuries, Traumatic
    • +2 more
      • Salt Lake City, Utah
        University of Utah Hospital
      Oct 30, 2018